Xylem (NYSE: XYL) reported Q3 EPS of $0.65, $0.01 better than the analyst estimate of $0.64. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.18 billion.

Full-year 2017 Outlook

Xylem now forecasts full-year 2017 revenue to be approximately $4.70 billion, up 24 to 25 percent, including growth from previously announced acquisitions and projected impacts of foreign exchange translation. On a pro forma organic basis, Xylem projects revenuegrowth of three to four percent.

Full-year 2017 adjusted operating margin is expected to be approximately 13.5 percent. The Company increased the mid-point of its full-year 2017 forecast for adjusted earnings per share by five cents. The Company now expects to deliver adjusted earnings per share of $2.39 to $2.41. This represents an increase of 18 to 19 percent from Xylem’s 2016 adjusted results. The Company’s adjusted earnings outlook excludes projected integration, restructuring and realignment costs, which now are forecast to be approximately $50 million for the year. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts, without unreasonable effort, that would be included in GAAP earnings.

GUIDANCE:

Xylem sees FY2017 EPS of $2.39-$2.41, versus the consensus of $2.38. Xylem sees FY2017 revenue of $4.7 billion, versus the consensus of $4.68 billion.

• Xylem generated $1.2 billion in third quarter 2017 revenue, up 33 percent year-over-year including the impact of acquisitions; Pro forma organic revenue increased five percent
• Third quarter reported net income was $105 million or $0.58 per share; Adjusted net income for the quarter was $119 million or $0.65 per share, up 20 percent versus the prior year period
• Global orders grew six percent organically
• Reported operating margin increased 50 basis points to 12.7 percent; Adjusted operating margin increased 20 basis points excluding purchase accounting impact
• Xylem raised the mid-point of its full-year 2017 forecast for adjusted earnings per share by five cents; the updated range is $2.39 to $2.41

For earnings history and earnings-related data on Xylem (XYL) click here.